Featured Content

Early Severity of Oxaliplatin-induced Neuropathy Predicts Later Severity

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

Multigene Testing for HBOC Clinically Valuable

Multigene panel testing can identify mutations that warrant management changes in patients who lack BRCA1 and 2.

Patient Voice Important in Reporting Cancer Symptoms

A prescription drug's label AE section is almost entirely based on clinicians' impression of patients' symptoms, not the patients' own reports.

AI/Bisphosphonate Combo May Improve Survival in Breast Cancer

The use of combination aromatase inhibitors with bisphosphonates could help reduce breast cancer mortality in postmenopausal women.

Drug Manufacturers Delayed Reporting AEs

One in every 10 serious adverse drug events, including deaths, was not reported to the FDA within regulation timelines.

Breast Cancer Resources

More Breast Cancer Information

How to Communicate Metastatic Breast Cancer Pain

This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.

Molecular Profiling: Personalizing Breast Cancer Treatment

This patient information fact sheet reviews how doctors use molecular profiling to offer patients more targeted therapy options.

BRCA1 and BRCA2: Cancer Risk and Genetic Testing

This fact sheet provides information about the BRCA1 and BRCA2 genes and related genetic testing.

Can Antiperspirants/Deodorants Cause Breast Cancer?

This fact sheet discusses evidence behind if antiperspirants and deodorants may be linked to breast cancer.

Hormone Therapy in Breast Cancer

This fact sheet teaches patients how hormone therapy can help stop the growth of hormone-sensitive breast cancer tumors.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs